- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Alzheimer’s Disease
Volume 2012 (2012), Article ID 406561, 6 pages
MicroRNAs and the Regulation of Tau Metabolism
1Axe Neurosciences, Centre de Recherche du CHUQ (CHUL), Québec, QC, Canada G1V 4G2
2Département de Psychiatrie et de Neurosciences, Faculté de Médecine, Université Laval, Québec, QC, Canada G1V 0A6
3Faculté de Médecine, Université Lille-Nord de France, UDSL, 59044 Lille, France
4Inserm, UMR837, 59045 Lille, France
Received 24 February 2012; Accepted 19 April 2012
Academic Editor: Lars M. Ittner
Copyright © 2012 Sébastien S. Hébert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. C. Lee, R. L. Feinbaum, and V. Ambros, “The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14,” Cell, vol. 75, no. 5, pp. 843–854, 1993.
- R. Lee, R. Feinbaum, and V. Ambros, “A short history of a short RNA,” Cell, vol. 116, pp. S89–S92, 2004.
- L. Ma and R. A. Weinberg, “Micromanagers of malignancy: role of microRNAs in regulating metastasis,” Trends in Genetics, vol. 24, no. 9, pp. 448–456, 2008.
- S. P. Nana-Sinkam and C. M. Croce, “MicroRNAs as therapeutic targets in cancer,” Translational Research, vol. 157, no. 4, pp. 216–225, 2011.
- S. S. Hébert and B. de Strooper, “Alterations of the microRNA network cause neurodegenerative disease,” Trends in Neurosciences, vol. 32, no. 4, pp. 199–206, 2009.
- E. A. Miska, E. Alvarez-Saavedra, M. Townsend et al., “Microarray analysis of microRNA expression in the developing mammalian brain,” Genome Biology, vol. 5, no. 9, p. R68, 2004.
- O. Barad, E. Meiri, A. Avniel et al., “MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues,” Genome Research, vol. 14, no. 12, pp. 2486–2494, 2004.
- L. F. Sempere, S. Freemantle, I. Pitha-Rowe, E. Moss, E. Dmitrovsky, and V. Ambros, “Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation,” Genome biology, vol. 5, no. 3, p. R13, 2004.
- N. Y. Shao, H. Y. Hu, Z. Yan et al., “Comprehensive survey of human brain microRNA by deep sequencing,” BMC Genomics, vol. 11, p. 409, 2010.
- J. E. Babiarz, R. Hsu, C. Melton, M. Thomas, E. M. Ullian, and R. Blelloch, “A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing,” RNA, vol. 17, no. 8, pp. 1489–1501, 2011.
- S. Vasudevan, Y. Tong, and J. A. Steitz, “Switching from repression to activation: microRNAs can up-regulate translation,” Science, vol. 318, no. 5858, pp. 1931–1934, 2007.
- R. F. Place, L. C. Li, D. Pookot, E. J. Noonan, and R. Dahiya, “MicroRNA-373 induces expression of genes with complementary promoter sequences,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 5, pp. 1608–1613, 2008.
- D. Baek, J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, “The impact of microRNAs on protein output,” Nature, vol. 455, no. 7209, pp. 64–71, 2008.
- M. Selbach, B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky, “Widespread changes in protein synthesis induced by microRNAs,” Nature, vol. 455, no. 7209, pp. 58–63, 2008.
- L. Buée, T. Bussière, V. Buée-Scherrer, A. Delacourte, and P. R. Hof, “Tau protein isoforms, phosphorylation and role in neurodegenerative disorders,” Brain Research Reviews, vol. 33, no. 1, pp. 95–130, 2000.
- M. Morris, S. Maeda, K. Vossel, and L. Mucke, “The Many faces of tau,” Neuron, vol. 70, no. 3, pp. 410–426, 2011.
- R. Brandt and J. Leschik, “Functional interactions of tau and their relevance for Alzheimer's disease,” Current Alzheimer Research, vol. 1, no. 4, pp. 255–269, 2004.
- L. M. Ittner, Y. D. Ke, F. Delerue et al., “Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models,” Cell, vol. 142, no. 3, pp. 387–397, 2010.
- P. J. Chapple, K. Anthony, T. R. Martin, A. Dev, T. A. Cooper, and J. M. Gallo, “Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4,” Human Molecular Genetics, vol. 16, no. 22, pp. 2760–2769, 2007.
- A. Andreadis, “Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases,” Biochimica Et Biophysica Acta, vol. 1739, no. 2, pp. 91–103, 2005.
- N. Sergeant, A. Bretteville, M. Hamdane et al., “Biochemistry of Tau in Alzheimer's disease and related neurological disorders,” Expert Review of Proteomics, vol. 5, no. 2, pp. 207–224, 2008.
- L. Buée, L. Troquier, S. Burnouf et al., “From tau phosphorylation to tau aggregation: what about neuronal death?” Biochemical Society Transactions, vol. 38, no. 4, pp. 967–972, 2010.
- J. Bilen, N. Liu, B. G. Burnett, R. N. Pittman, and N. M. Bonini, “MicroRNA pathways modulate polyglutamine-induced neurodegeneration,” Molecular Cell, vol. 24, no. 1, pp. 157–163, 2006.
- D. C. Carrettiero, I. Hernandez, P. Neveu, T. Papagiannakopoulos, and K. S. Kosik, “The cochaperone BAG2 sweeps paired helical filament-insoluble tau from the microtubule,” Journal of Neuroscience, vol. 29, no. 7, pp. 2151–2161, 2009.
- S. S. Hébert, A. S. Papadopoulou, P. Smith et al., “Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration,” Human Molecular Genetics, vol. 19, no. 20, pp. 3959–3969, 2010.
- P. Y. Smith, C. Delay, J. Girard et al., “MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy,” Human Molecular Genetics, vol. 20, no. 20, pp. 4016–4024, 2011.
- D. P. Hanger and W. Noble, “Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation,” International Journal of Alzheimer's Disease, vol. 2011, Article ID 352805, 11 pages, 2011.
- A. Sultan, F. Nesslany, M. Violet et al., “Nuclear Tau, a key player in neuronal DNA protection,” Journal of Biological Chemistry, vol. 286, no. 6, pp. 4566–4575, 2011.
- R. A. Whittington, M. A. Papon, F. Chouinard, and E. Planel, “Hypothermia and Alzheimer's disease neuropathogenic pathways,” Current Alzheimer Research, vol. 7, no. 8, pp. 717–725, 2010.
- E. Planel, A. Bretteville, L. Liu et al., “Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia,” The FASEB Journal, vol. 23, no. 8, pp. 2595–2604, 2009.
- Y. Okawa, K. Ishiguro, S. C. Fujita, and J. Avila, “Stress-induced hyperphosphorylation of tau in the mouse brain,” FEBS Letters, vol. 535, no. 1–3, pp. 183–189, 2003.
- M. Yanagisawa, E. Planel, K. Ishiguro, and S. C. Fujita, “Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease,” FEBS Letters, vol. 461, no. 3, pp. 329–333, 1999.
- W. Qian, H. Liang, J. Shi et al., “Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A,” Nucleic Acids Research, vol. 39, no. 14, pp. 6161–6171, 2011.
- J. Shi, W. Qian, X. Yin et al., “Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease,” Journal of Biological Chemistry, vol. 286, no. 16, pp. 14639–14648, 2011.
- D. C. Glatz, D. Rujescu, Y. Tang et al., “The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease,” Journal of Neurochemistry, vol. 96, no. 3, pp. 635–644, 2006.
- F. Hernández, M. Pérez, J. J. Lucas, A. M. Mata, R. Bhat, and J. Avila, “Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35: implications for Alzheimer's disease,” Journal of Biological Chemistry, vol. 279, no. 5, pp. 3801–3806, 2004.
- J. S. Mohamed, M. A. Lopez, and A. M. Boriek, “Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3β,” Journal of Biological Chemistry, vol. 285, no. 38, pp. 29336–29347, 2010.
- Z. Yang, S. Chen, X. Luan et al., “MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of hela cells,” IUBMB Life, vol. 61, no. 11, pp. 1075–1082, 2009.
- I. Ferrer, R. Blanco, M. Carmona et al., “Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration,” Brain Pathology, vol. 11, no. 2, pp. 144–158, 2001.
- K. Iqbal, C. Alonso Adel, E. El-Akkad et al., “Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion,” Journal of Molecular Neuroscience, vol. 19, no. 1-2, pp. 95–99, 2002.
- G. Perry, H. Roder, A. Nunomura et al., “Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation,” NeuroReport, vol. 10, no. 11, pp. 2411–2415, 1999.
- Y. Satoh, Y. Kobayashi, A. Takeuchi, G. Pagès, J. Pouysségur, and T. Kazama, “Deletion of ERK1 and ERK2 in the CNS causes cortical abnormalities and neonatal lethality: Erk1 deficiency enhances the impairment of neurogenesis in Erk2-deficient mice,” Journal of Neuroscience, vol. 31, no. 3, pp. 1149–1155, 2011.
- S. Subramaniam and K. Unsicker, “ERK and cell death: ERK1/2 in neuronal death,” The FEBS Journal, vol. 277, no. 1, pp. 22–29, 2010.
- O. Natera-Naranjo, A. Aschrafi, A. E. Gioio, and B. B. Kaplan, “Identification and quantitative analyses of microRNAs located in the distal axons of sympathetic neurons,” RNA, vol. 16, no. 8, pp. 1516–1529, 2010.
- J. P. Cogswell, J. Ward, I. A. Taylor et al., “Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways,” Journal of Alzheimer's Disease, vol. 14, no. 1, pp. 27–41, 2008.
- J. Nunez-Iglesias, C.-C. Liu, T. E. Morgan, C. E. Finch, and X. J. Zhou, “Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation,” PloS One, vol. 5, no. 2, p. e8898, 2010.
- A. Cimmino, G. A. Calin, M. Fabbri et al., “MiR-15 and miR-16 induce apoptosis by targeting BCL2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 13944–13949, 2005.
- G. Lu, W. H. Kwong, Q. Li, X. Wang, Z. Feng, and D. T. Yew, “Bcl2, bax, and nestin in the brains of patients with neurodegeneration and those of normal aging,” Journal of Molecular Neuroscience, vol. 27, no. 2, pp. 167–174, 2005.
- K. L. Jordan-Sciutto, L. M. Malaiyandi, and R. Bowser, “Altered distribution of cell cycle transcriptional regulators during Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 61, no. 4, pp. 358–367, 2002.
- W. Liu, C. Liu, J. Zhu et al., “MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice,” Neurobiology of Aging, vol. 33, pp. 522–534, 2012.
- J. T. Zipprich, S. Bhattacharyya, H. Mathys, and W. Filipowicz, “Importance of the C-Terminal domain of the human GW182 protein TNRC6C for translational repression,” RNA, vol. 15, no. 5, pp. 781–793, 2009.
- P. Ray, A. Kar, K. Fushimi, N. Havlioglu, X. Chen, and J. Y. Wu, “PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10,” Journal of Molecular Neuroscience, vol. 45, no. 3, pp. 453–466, 2011.
- C. F. Sephton, C. Cenik, A. Kucukural et al., “Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes,” Journal of Biological Chemistry, vol. 286, no. 2, pp. 1204–1215, 2011.
- M. L. Wei, J. Memmott, G. Screaton, and A. Andreadis, “The splicing determinants of a regulated exon in the axonal MAP tau reside within the exon and in its upstream intron,” Molecular Brain Research, vol. 80, no. 2, pp. 207–218, 2000.
- J. Wang, Q. S. Gao, Y. Wang, R. Lafyatis, S. Stamm, and A. Andreadis, “Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors,” Journal of Neurochemistry, vol. 88, no. 5, pp. 1078–1090, 2004.
- S. S. Hébert, K. Horré, L. Nicolaï et al., “Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6415–6420, 2008.
- P. Smith, A. Al Hashimi, J. Girard, C. Delay, and S. S. Hébert, “In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs,” Journal of Neurochemistry, vol. 116, no. 2, pp. 240–247, 2011.
- W. J. Lukiw, “Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus,” Neuroreport, vol. 18, no. 3, pp. 297–300, 2007.
- N. Schonrock, Y. D. Ke, D. Humphreys et al., “Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-β,” PloS one, vol. 5, no. 6, p. e11070, 2010.
- K. Yasojima, E. G. McGeer, and P. L. McGeer, “Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA,” Brain Research, vol. 831, no. 1-2, pp. 301–305, 1999.
- T. M. Caffrey, C. Joachim, S. Paracchini, M. M. Esiri, and R. Wade-Martins, “Haplotype-specific expression of exon 10 at the human MAPT locus,” Human Molecular Genetics, vol. 15, no. 24, pp. 3529–3537, 2006.
- J. C. Steele, J. C. Richardson, and J. Olszewski, “Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia,” Archives of Neurology, vol. 10, pp. 333–359, 1964.
- J. R. Tollervey, Z. Wang, T. Hortobágyi et al., “Analysis of alternative splicing associated with aging and neurodegeneration in the human brain,” Genome Research, vol. 21, no. 10, pp. 1572–1582, 2011.
- T. Sterne-Weiler, J. Howard, M. Mort, D. N. Cooper, and J. R. Sanford, “Loss of exon identity is a common mechanism of human inherited disease,” Genome Research, vol. 21, no. 10, pp. 1563–1571, 2011.